Article Text

Download PDFPDF
Association of IL2RA and IL2RB with rheumatoid arthritis: a replication study in a Dutch population
  1. F A S Kurreeman1,
  2. N A Daha1,
  3. M Chang2,
  4. J J Catanese2,
  5. A B Begovich2,
  6. T W J Huizinga1,
  7. R E M Toes1
  1. 1
    Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
  2. 2
    Celera, Alameda, California, USA
  1. Correspondence to Professor R E M Toes, Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; r.e.m.toes{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Rheumatoid arthritis (RA) is an autoimmune disease with a worldwide prevalence of approximately 1%. The aetiology of RA is largely unknown, but it is thought that both genetic and environmental factors play a role in the pathogenesis of the disease. Genome-wide association studies (GWAS) and candidate gene approaches have led to the association of a number of genetic susceptibility loci.1 2 3 4 5 6 7 The Wellcome Trust case-control consortium (WTCCC), the first GWAS in RA, identified a number of loci reaching genome-wide significance including the HLA region and the PTPN22 gene.5 To identify new genetic risk factors, Thomson et al investigated whether tier 2 single nucleotide polymorphisms (SNPs) (p = 1×10−5−1×10−7) in the WTCCC-GWAS showed an association with RA in an independent validation study …

View Full Text


  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • FASK and NAD contributed equally to the paper.

  • ABB is currently affiliated with Roche Diagnostics, Pleasanton, California, USA